Liberty Square Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$728K Buy
791
+1
+0.1% +$1.01K 0.2% 54
2025
Q4
$849K Sell
790
-50
-6% -$47.8K 0.24% 52
2025
Q3
$641K Hold
840
0.2% 68
2025
Q2
$655K Buy
840
+114
+16% +$88.6K 0.23% 63
2025
Q1
$600K Buy
726
+22
+3% +$18.3K 0.23% 68
2024
Q4
$594K Buy
+704
New +$583K 0.22% 70

Other funds holding LLY

Liberty Square Wealth Partners's LLY Position: Q1 2026 in Review

Liberty Square Wealth Partners increased its Eli Lilly (LLY) stake by 0.13% in Q1 2026, buying an estimated $1.01K and bringing the position to 791 shares worth $728K. The position accounts for 0.2% of the portfolio, ranked #54.

Liberty Square Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $849K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Liberty Square Wealth Partners held 791 shares of Eli Lilly worth $728K as of Q1 2026.
  • Liberty Square Wealth Partners bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.2% of Liberty Square Wealth Partners's portfolio in Q1 2026, its #54 holding.
  • Liberty Square Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Liberty Square Wealth Partners's Eli Lilly position peaked at $849K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Liberty Square Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.